Oral retinoic acid as therapy for erythrokeratoderma variabilis*

Abstract
Oral retinoic acid successfully and rapidly helped two patients with erythrokeratoderma variabilis. Treatment had to be maintained to prevent recurrence and no side effects have been observed so far.